These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35569003)

  • 1. Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials.
    Huang J; Kang D; Zhang F; Yang Y; Liu C; Xiao J; Long Y; Lang B; Peng X; Wang W; Wang X; Liu F; Davis JM; Zhao J; Wu R
    Schizophr Bull; 2022 Jun; 48(4):850-859. PubMed ID: 35569003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
    Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trial.
    Liu C; Kang D; Xiao J; Huang Y; Peng X; Wang W; Xie P; Yang Y; Zhao J; Wu R
    Trials; 2021 Feb; 22(1):159. PubMed ID: 33622382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of probiotics plus dietary fiber on antipsychotic-induced weight gain: a randomized clinical trial.
    Huang J; Liu C; Yang Y; Kang D; Xiao J; Long Y; Lang B; Peng X; Wang W; Wang X; Liu F; Zhao J; Shi Z; Yuan TF; Wu R
    Transl Psychiatry; 2022 May; 12(1):185. PubMed ID: 35508529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study.
    Correll CU; Newcomer JW; Silverman B; DiPetrillo L; Graham C; Jiang Y; Du Y; Simmons A; Hopkinson C; McDonnell D; Kahn RS
    Am J Psychiatry; 2020 Dec; 177(12):1168-1178. PubMed ID: 32791894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia.
    Martin WF; Correll CU; Weiden PJ; Jiang Y; Pathak S; DiPetrillo L; Silverman BL; Ehrich EW
    Am J Psychiatry; 2019 Jun; 176(6):457-467. PubMed ID: 30845818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis.
    Correll CU; Højlund M; Graham C; Todtenkopf MS; McDonnell D; Simmons A
    Int J Neuropsychopharmacol; 2023 Jul; 26(7):451-464. PubMed ID: 37326421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study.
    Poyurovsky M; Isaacs I; Fuchs C; Schneidman M; Faragian S; Weizman R; Weizman A
    Am J Psychiatry; 2003 Feb; 160(2):297-302. PubMed ID: 12562576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study.
    Poyurovsky M; Tal V; Maayan R; Gil-Ad I; Fuchs C; Weizman A
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):332-6. PubMed ID: 15163444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial.
    Narula PK; Rehan HS; Unni KE; Gupta N
    Schizophr Res; 2010 May; 118(1-3):218-23. PubMed ID: 20207521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics-based understanding of the olanzapine-induced weight gain in female first-episode drug-naïve patients with schizophrenia.
    Liu JH; Chen N; Guo YH; Guan XN; Wang J; Wang D; Xiu MH
    J Psychiatr Res; 2021 Aug; 140():409-415. PubMed ID: 34144444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients.
    Poyurovsky M; Pashinian A; Levi A; Weizman R; Weizman A
    Int Clin Psychopharmacol; 2005 Mar; 20(2):101-3. PubMed ID: 15729086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of continuous theta burst stimulation on antipsychotic-induced weight gain in first-episode drug-naive individuals with schizophrenia: a double-blind, randomized, sham-controlled feasibility trial.
    Kang D; Song C; Peng X; Yu G; Yang Y; Chen C; Long Y; Shao P; Wu R
    Transl Psychiatry; 2024 Jan; 14(1):61. PubMed ID: 38272892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial.
    Schmidt-Kraepelin C; Feyerabend S; Engelke C; Riesbeck M; Meisenzahl-Lechner E; Verde PE; Correll CU; Kluge M; Makiol C; Neff A; Lange C; Englisch S; Zink M; Langguth B; Poeppl TB; Reske D; Gouzoulis-Mayfrank E; Gründer G; Hasan A; Brockhaus-Dumke A; Jäger M; Baumgärtner J; Leucht S; Cordes J;
    Lancet Psychiatry; 2022 Apr; 9(4):291-306. PubMed ID: 35276079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early prediction of olanzapine-induced weight gain for schizophrenia patients.
    Lin CH; Lin SC; Huang YH; Wang FC; Huang CJ
    Psychiatry Res; 2018 May; 263():207-211. PubMed ID: 29574355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder.
    Detke HC; DelBello MP; Landry J; Hoffmann VP; Heinloth A; Dittmann RW
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):922-934. PubMed ID: 27676420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study.
    Poyurovsky M; Fuchs C; Pashinian A; Levi A; Faragian S; Maayan R; Gil-Ad I
    Psychopharmacology (Berl); 2007 Jun; 192(3):441-8. PubMed ID: 17310385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine/Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain.
    Corrao MM; Nelson LA
    CNS Drugs; 2022 Jun; 36(6):605-616. PubMed ID: 35644903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
    Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
    JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.